keyword
MENU ▼
Read by QxMD icon Read
search

etoposide with cisplatin mCRPC

keyword
https://www.readbyqxmd.com/read/26807222/carboplatin-etoposide-combination-chemotherapy-in-metastatic-castration-resistant-prostate-cancer-a-retrospective-study
#1
Matthieu Caubet, Erion Dobi, Astrid Pozet, Hamadi Almotlak, Philippe Montcuquet, Tristan Maurina, Guillaume Mouillet, Thierry N'guyen, Ulrich Stein, Antoine Thiery-Vuillemin, Frederic Fiteni
The combination of cisplatin or carboplatin and etoposide is the standard treatment for certain poorly differentiated neuroendocrine cancers, such as small-cell lung cancer. The aim of this study was to assess the efficacy and tolerability of the carboplatin-etoposide regimen in metastatic castration-resistant prostate cancer (mCRPC). A total of 27 patients treated by carboplatin [area under the curve (AUC)=5] and etoposide (100 mg/m(2) intravenous infusion on days 1-3 or 75 mg orally/day for 10 days) for mCRPC were included for analysis...
November 2015: Molecular and Clinical Oncology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"